Ascentage Pharma
AAPG16.8053.56% ( -0.620 )
H2 2025 Earnings
Financial report interval: 2025.07.01 - 2025.12.31
Preview: Ascentage Pharma(AAPG) predict that the Revenue is 340.42 M (--%), Beat estimate;the EBIT is -591.21 M (--%), Miss estimate;the EPS is -1.04 (+44.97%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.34B--
0.31B--
+0.03B--%
EBITMiss expectations
-0.59B--
-0.51B--
-0.08B--%
EPSMiss expectations
-1.0444.97%
-0.413378.13%
-0.626733.16%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf